Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma

doi:10.3748/wjg.v20.i35.12588

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 35

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4184)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

315

WORD

192

HTML

2510

Figures (1-1)

Tables (1-3)

106

Sum=3221

Sep 21, 2014 (publication date) through Apr 15, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 21, 2014; 20(35): 12588-12594
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12588

Open in New Tab Full Size Figure Download Figure

Figure 1 Flow diagram shows algorithm of enrolled patients. Ninety-four patients were analyzed for this study who are alive without recurrence of HCC at 1 year after combination of TACE+RFA. HCC: Hepatocellular carcinoma; intra-OP: Intra-operative; RFA: Radiofrequency ablation; RT: Radiation therapy; TACE: Transcatheter arterial chemoembolization.

Citation: Choe WH, Kim YJ, Park HS, Park SW, Kim JH, Kwon SY. Short-term interval combined chemoembolization and radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(35): 12588-12594
URL: https://www.wjgnet.com/1007-9327/full/v20/i35/12588.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i35.12588